US

SMART THERAPY AS UNIQUE AS YOU

Saluda Medical is transforming patients’ lives with disruptive neuromodulation solutions

The Evoke® System Is The Only SmartSCS™ Therapy For Chronic Pain

While spinal cord stimulation (SCS) therapy has been around for more than 50 years, there’s a smarter treatment option that can help you regain your life. The Evoke® System listens to your body’s needs and automatically adjusts therapy in real time so that you can focus less on your pain and more on living your life.

Birgit van den Heuvel

Birgit’s Story

I have such a lust for life again, I want to do things again. This gives me so much freedom.

Birgit
Evoke® System patient

What Is The Evoke® SmartSCS™ System?

It’s a small device that safely works inside your body to provide lasting pain relief and restore your quality of life.1

  • Safe, Non-Drug Therapy
  • Minimally Invasive
  • Try Before You Decide
Figure of human with dots on it
Women on bike

The Evoke® System is smart because it constantly listens to your body’s needs and automatically adjusts therapy 4+ million times per day*

A Proven Treatment

The most durable patient outcomes from a randomized control study in SCS history with 36-month data 1

The Evoke® System was approved based on the most rigorous clinical study in the history of spinal cord stimulation of 134 patients.

Saluda Medical’s Evoke® SCS System delivered pain relief and clinically superior therapy1. The EVOKE Study reported industry-leading quality of life outcomes when compared to current SCS systems.

Long-Lasting Relief And Improved Quality Of Life

4 dot's line

Pain Relief

Nearly 83% experienced long-term pain relief

5 dot's cross

Quality Of Life

More than 81% experienced better quality of life

4 dot's vertical line

Mood

68% experienced better mood

3x3 dot's square

Functional Ability

Nearly 85% had improved function to perform daily activities

4 dot's horizontal line

Sleep

Patients gained on average more than 1 hour of additional sleep per night

93%

Patient Satisfaction

55%

Voluntarily reduced or eliminated opioids

One of the largest health care payors in the world the US Centers for Medicare and Medicaid Services (CMS) has stated, We believe this RCT (EVOKE Study)comparison served to demonstrate substantial clinical improvement over existing SCS devices and created a new device category for Medicare reimbursement.

2023 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, the Department of Health and Human Services, Centers for Medicare and Medicaid Services.

You Are Able To Trial The Evoke® System Before Deciding To Get The Permanent Implant

  • One of the advantages of SCS therapy is that you can try it before deciding on a permanent implant.
  • The goal of the trial is to reduce your pain by at least 50% and improve your ability to do the things you find challenging due to your pain.
  • In the Clinical Study for FDA approval of the Evoke® System, 83% of patients experienced a 50% or greater reduction in pain and 59% of patients experienced a 80% or greater reduction in pain, as well as improvements in quality of life, functional status, mood and sleep. 1
Trial-Device-Illustration-w-bandage

Interested In Trialing The Evoke® System?